Scientist - Imaging Research and Development at Eli Lilly and Company

Philadelphia, Pennsylvania, United States

Eli Lilly and Company Logo
Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, BiotechnologyIndustries

Requirements

  • Degree in physical or biological sciences or imaging-related field
  • Bachelor’s degree with minimum of 10 years’ experience or master’s with a minimum of 8 years’ experience in scientific field

Responsibilities

  • Establish and execute imaging research projects supporting oncology, neuroscience or other drug discovery and biomarker projects
  • Design and conduct novel binding assays, including radioligand binding assays
  • Characterize and purify biological targets
  • Collaborate with internal project teams, implement translatable imaging biomarker assays and ensure seamless translation of projects
  • Publish results of research projects as appropriate
  • Participate in extramural scientific organizations and attend scientific symposia as well as workshops in order to continue educational/professional development
  • Other duties as assigned

Skills

Key technologies and capabilities for this role

Molecular ImagingPET ImagingRadioligand Binding AssaysBinding AssaysBiological Assay DevelopmentBiomarker AssaysData AnalysisNeuroscience ImagingOncology Imaging

Questions & Answers

Common questions about this position

What are the basic education and experience requirements for this Scientist role?

Candidates need a degree in physical or biological sciences or imaging-related field, with a Bachelor’s degree and minimum of 10 years’ experience or a master’s with a minimum of 8 years’ experience in a scientific field.

What preferred skills or experiences are highlighted for this position?

Preferred skills include experience with in vitro assay development, in Oncology or Neuroscience preferably in molecular imaging, designing and executing novel biochemical/cellular/tissue assays including radioligand binding assays, working with amyloidogenic proteins, independently characterizing and purifying biological targets, experience in PET imaging agents, peer-reviewed publications, and willingness to engage in professional development.

Is the salary or compensation specified for this Scientist position?

This information is not specified in the job description.

What is the work arrangement or location policy for this role at Eli Lilly?

This information is not specified in the job description.

What does Eli Lilly's company culture emphasize for employees?

Eli Lilly emphasizes uniting caring with discovery to make life better for people, putting people first, serving an extraordinary purpose through discovering and delivering medicines, and giving back to communities through philanthropy and volunteerism.

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI